GlassScriptPhysician profile
Silvia Diego
NPI 1922080506
$5,803.64
in general payments reported to CMS, 2019-2025
49 companies · $776 in 2025
The $776 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,164 · 2020: $776 · 2021: $910 · 2022: $440 · 2023: $772 · 2024: $966 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,496 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,495.72 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $876.51 | 2019-2025 | Evenity, Tezspire, Prolia |
| Lilly USA, LLC | $633.38 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $582.02 | 2019-2023 | Enhertu, Farxiga |
| Novo Nordisk INC | $554.88 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $508.46 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.54 | 2019-2025 | Jardiance |
| Abbvie INC. | $253.97 | 2019-2023 | Vraylar |
| Amarin Pharma, INC. | $164.25 | 2019-2021 | |
| Astellas Pharma US INC | $148.55 | 2019-2024 | Veozah |
| Mayne Pharma Commercial LLC | $147.96 | 2025 | Bijuva |
| Biohaven Pharmaceutical Holding Company LTD. | $141.53 | 2022 | |
| Sanofi Pasteur INC. | $121.47 | 2019-2025 | |
| Exact Sciences Corporation | $116.89 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $95.82 | 2019-2023 | Vaxneuvance, Proquad, Vaxelis |
| Dexcom, INC. | $92.08 | 2022-2023 | Dexcom G6 Transmitter |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silvia Diego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.